Louis Malspeis
- Molecular Biology top 5%
- Oncology top 5%
- Organic Chemistry top 5%
- Pharmacology top 5%
- Cell Biology top 5%
- Co-authors
- Jeffrey G. SupkoMichael R. GreverRobert L. HickmanKenneth D. PaullErnest HamelJoseph G. MayoMichael C. AlleyMelinda G. Hollingshead
- Topics
- Cancer therapeutics and mechanisms (16 papers)HIV/AIDS drug development and treatment (9 papers)Biochemical and Molecular Research (8 papers)
- Cited by
- ToxicologyVirologyOncology
- Partner nations
- United StatesMalaysiaUkraine
In The Last Decade
Louis Malspeis
81 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 126
- Molecular Biology 1.5k
- Oncology 682
- Organic Chemistry 438
- Pharmacology 339
- Cell Biology 263
Countries citing papers authored by Louis Malspeis
This map shows the geographic impact of Louis Malspeis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Malspeis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Malspeis more than expected).
Fields of papers citing papers by Louis Malspeis
This network shows the impact of papers produced by Louis Malspeis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Malspeis. The network helps show where Louis Malspeis may publish in the future.
Co-authorship network of co-authors of Louis Malspeis
This figure shows the co-authorship network connecting the top 25 collaborators of Louis Malspeis. A scholar is included among the top collaborators of Louis Malspeis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Malspeis. Louis Malspeis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 25 | |
| 3 | 25 | |
| 4 | 6 | |
| 5 | 22 | |
| 6 | 44 | |
| 7 | 131 | |
| 8 | 407 | |
| 9 | Tyrphostin AG17, [(3,5-Di-tert-butyl-4-hydroxybenzylidene)- malononitrile], inhibits cell growth by disrupting mitochondria. | 41 |
| 10 | 10 | |
| 11 | 32 | |
| 12 | 20 | |
| 13 | Phase II trial of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity. | 75 |
| 14 | 20 | |
| 15 | Phase I trial of teroxirone. | 3 |
| 16 | 29 | |
| 17 | Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibition. | 45 |
| 18 | Systolic time intervals in monitoring adriamycin-induced cardiotoxicity. | 21 |
| 19 | 10 | |
| 20 | 13 |
About Louis Malspeis
Louis Malspeis is a scholar working on Virology, Organic Chemistry and Pharmacology, having authored 83 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (16 papers), HIV/AIDS drug development and treatment (9 papers) and Biochemical and Molecular Research (8 papers). The work is most often cited by research in Toxicology (153 citations), Virology (172 citations) and Oncology (682 citations). Louis Malspeis has collaborated with scholars based in United States, Malaysia and Ukraine. Frequent co-authors include Jeffrey G. Supko, Michael R. Grever, Robert L. Hickman, Kenneth D. Paull, Ernest Hamel, Joseph G. Mayo, Michael C. Alley, Melinda G. Hollingshead, Cherry L. Herald and George R. Pettit. Their work appears in journals such as Science, Journal of Biological Chemistry and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.